Behandlingsrelaterede bivirkninger indberettet hos > 2% af patienter med solide tumorer er anført nedenfor efter organklasse, hyppighed og sværhedsgrad.
Treatment-related adverse reactions that were reported in > 2% of solid tumour patients are listed below, by system organ class, frequency and grade of severity.